← Leaderboards
Robert Jenq
Sloan-Kettering Inst Can Research
$9,366,718
Attributed
$9,366,718
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $4.7M · FY2015–25$5M$3.8M$2.5M$1.3M$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$14,399,223 · 4
By mechanism
P01$7,583,570 · 3
R01$6,815,653 · 1
Top collaborators
No co-investigators on record.
Most similar at Sloan-Kettering Inst Can Research
Same institution · by research overlap
- Alan M Hanash$10,698,469
- Andrew Y Koh$4,547,928
Others in their field
Top investigators on “Bacteria”
- James E. Gern · University Of Wisconsin-Madison$138,333,846
- Ian A Wilson · Scripps Research Institute, The$90,122,969
- Vance G Fowler · Duke University$85,101,521
- Henry F Chambers · Duke University$84,838,080
- Timothy Henkel · Venatorx Pharmaceuticals, Inc.$48,397,895
- David Alland · Rutgers Biomedical And Health Sciences$47,292,355
Research focus
BacteriaMouse ModelIntestinesAntibioticsTransplant RecipientsAllogenicMicrobiotaLinkMucous Body SubstanceMucinsToxic EffectExperimental StudyMalignant NeoplasmsInflammationConditioningIntestinal Graft Versus Host DiseaseGraft Vs Host DiseaseImmuneMediatingChemotherapyLifeBiometryMucolyticsCells
Grant awards (17)
Mucus-degrading intestinal bacteria and toxicities of hematopoietic cell transplantation$2,312,989
P01 · FY2025 · HL · contact PI
Mucin preserving strategies to reduce allo HCT toxicities$766,760
P01 · FY2025 · HL · contact PI
Administrative, biospecimen and biostatistical core$466,651
P01 · FY2025 · HL · contact PI
Mucus-degrading intestinal bacteria and toxicities of hematopoietic cell transplantation$124,972
P01 · FY2025 · HL · contact PI
Mucus-degrading intestinal bacteria and toxicities of hematopoietic cell transplantation$2,594,544
P01 · FY2024 · HL · contact PI
Protecting colonic mucus to mitigate acute intestinal graft-versus-host disease$791,323
R01 · FY2024 · HL · contact PI
Mucin preserving strategies to reduce allo HCT toxicities$775,660
P01 · FY2024 · HL · contact PI
Administrative, biospecimen and biostatistical core$541,994
P01 · FY2024 · HL · contact PI
Protecting colonic mucus to mitigate acute intestinal graft-versus-host disease$807,472
R01 · FY2023 · HL · contact PI
Protecting colonic mucus to mitigate acute intestinal graft-versus-host disease$807,472
R01 · FY2022 · HL · contact PI
Protecting colonic mucus to mitigate acute intestinal graft-versus-host disease$812,650
R01 · FY2021 · HL · contact PI
Protecting colonic mucus to mitigate acute intestinal graft-versus-host disease$833,292
R01 · FY2020 · HL · contact PI
Microbiota-focused strategies to mitigate GVHD$512,611
R01 · FY2019 · HL · contact PI
Microbiota-focused strategies to mitigate GVHD$518,709
R01 · FY2018 · HL · contact PI
Microbiota-focused strategies to mitigate GVHD$538,525
R01 · FY2017 · HL · contact PI
Microbiota-focused strategies to mitigate GVHD$587,312
R01 · FY2016 · HL · contact PI
Microbiota-focused strategies to mitigate GVHD$606,287
R01 · FY2015 · HL · contact PI